![]() |
市場調查報告書
商品編碼
1479086
視力保健設備市場:現況分析與預測(2023-2030)Vision Care Devices Market: Current Analysis and Forecast (2023-2030) |
由於老年人口的增加,預計視力保健設備市場在預測期內將以 8% 的複合年增長率強勁增長。老年人口的增加是視力保健設備市場的主要驅動因素之一。隨著年齡的增長,人們的眼睛變得更容易出現白內障、黃斑部病變和青光眼等眼部疾病。根據國家眼科研究所的數據,超過一半的美國人將在 80 歲時患上白內障。此外,老年人患青光眼的風險更高。根據HealthinAging的數據,65歲以上的人中約有5%會患上青光眼,80歲以上的人中約有10%會患有青光眼。老年人可能還需要專門的視力保健設備來協助日常生活,例如放大鏡、低視力輔助設備和對比增強設備。例如,根據美國政府社區生活管理局 (ACL) 2022 年發佈的一份報告,在美國,大約一半 80 歲以上的成年人患有視力喪失。這促使對視力保健產品和服務的巨大需求,以保持獨立性和生活品質。隨著世界人口老化,對視力保健設備的需求預計將猛增,為服務於這一不斷增長的人口的公司創造一個強大的市場。
依類型,市場分為人工水晶體、青光眼引流裝置、隱形眼鏡、眼科雷射等。2022年的市場中,人工水晶體領域將佔據壓倒性的佔有率。人工水晶體 (IOL) 是一種植入眼睛的視力保健裝置,用於取代白內障手術期間摘除的自然水晶體或矯正屈光不正。由於多種因素,該領域正在不斷發展,包括眼科問題的增加、糖尿病患者白內障病例的增加以及先進優質人工水晶體的採用增加。據美國眼科學會稱,到 2021 年,近視(眼睛聚焦障礙)將成為一種嚴重的流行疾病,影響估計 25% 的美國人。此外,產品發佈數量的增加也推動了預測期內的市場成長。例如,2023年1月,Bausch + Lomb完成了對私人眼科醫療器材公司AcuFocus的收購。此次收購使 Bausch + Lomb 能夠獲得 AcuFocus 創新的小孔徑無技巧擴展焦深 (EDOF) 人工水晶體 (IOL) 技術,該技術目前在澳洲和紐西蘭上市。
依用途可分為手術、診斷和眼科護理。預計眼科護理產業在預測期內將以顯著的複合年增長率成長。由於眼睛問題日益增加、老年人口增加等諸多因素,民眾對視力矯正和改善的需求不斷增加,預計在預測期內視力保健產品的銷售量將會增加。此外,不良的飲食習慣和缺乏健康意識預計會增加對視力保健產品和服務的需求。
依最終用戶劃分,市場分為醫院、眼科中心等。到2022年,隨著白內障手術和視力恢復手術在這些設施中大量進行,醫院部門將佔據超過50.0%的主要市場。在發展中地區,不隸屬於醫院的獨立眼科診所的數量大幅增加,眼科護理提供者之間的競爭預計將加劇。這些診所以及越來越多的眼科從業者可以以具有競爭力的價格吸引患者,最終推動該領域的成長。
為了更瞭解義肢產業的市場採用情況,市場包括北美(美國、加拿大、北美其他地區)、歐洲(德國、英國、法國、西班牙、義大利、歐洲其他地區)、亞太地區(中國、日本) 、印度)、其他亞太地區)以及世界其他國家。北美在市場上佔據主導地位,預計這一趨勢在預測期內將持續下去。由於視力相關疾病的增加、醫療保健領域新技術和新產品的高採用率以及對更好醫療保健的需求激增,預計北美將在預測期內佔據研究市場的主要市場佔有率設施值得期待。此外,年齡相關性白內障和先天性白內障等白內障問題的日益流行預計將在預測期內推動市場成長。根據NVision Centers發佈的統計數據,到2022年,美國40歲以上的人將有約1,200萬人患有視力喪失。同樣,根據加拿大抗盲組織 2021 年 5 月的更新,2021 年有 120 萬加拿大人患有視力障礙。據同一消息來源稱,800 萬加拿大人患有可導致失明的眼部疾病。因此,由於眼部疾病發生率的上升和對人工水晶體的需求的增加,預計該市場將會發展。
市場上一些主要的參與者包括Johnson & Johnson、EssilorLuxottica、NIDEK CO., LTD、Ziemer Ophthalmic Systems AG、Bausch + Lomb、ZEISS Group、Tomey Corporation、Alcon、CooperVision、VisionCare Devicess。
The vision care devices market encompasses a wide range of products and services aimed at addressing various vision-related issues. This market includes eyeglasses, contact lenses, refractive surgery, and other vision enhancement technologies. With the growing global population and increasing prevalence of vision problems, the vision care devices market has witnessed significant growth in recent years. One of the key drivers of the vision care devices market is the rising incidence of vision problems, such as myopia, hyperopia, astigmatism, and presbyopia, which are often associated with factors like genetics, lifestyle changes, and increased screen time. As a result, the demand for corrective eyewear solutions has been steadily rising, leading to a surge in the sales of eyeglasses and contact lenses globally. In addition to corrective eyewear, the market for protective eyewear, such as sunglasses and safety glasses, has also been witnessing significant growth. With increasing awareness about the harmful effects of UV radiation on eye health, consumers are increasingly opting for sunglasses with UV protection to shield their eyes from the sun's rays.
The Vision Care Devices Market is expected to grow at a strong CAGR of 8% during the forecast period owing to increasing geriatric population. The rising geriatric population is one of the key driver in the vision care devices market. As humans age, their eyes become more susceptible to developing conditions like cataracts, macular degeneration, and glaucoma. According to the National Eye Institute, cataracts affect over half of all Americans by age 80. Moreover, the older person is also at a higher risk of developing glaucoma. According to HealthinAging, around 5% of people age 65 and older develop glaucoma and 10 percent of those age 80 and older develop it. The elderly population may also require specialized vision care devices like magnifiers, low-vision aids, or devices with enhanced contrast to help them perform daily activities. For instance, a 2022 report by the Administration for Community Living (ACL), part of the US government, highlights that nearly half of all adults aged 80 and over in the United States experience vision impairment. This translates to a significant demand for vision care products and services to maintain their independence and quality of life. As the global population ages, the demand for vision care devices is expected to surge, creating a strong market for companies catering to this growing demographic.
Based on the type, the market is segmented into intraocular lens, glaucoma drainage devices, contact lenses, ophthalmic lasers, and others. The intraocular lens segment held a dominant share of the market in 2022. Intraocular lenses (IOLs) are vision care devices that are implanted within the eye to replace the natural lens after its removal during cataract surgery or to correct refractive errors. The segment is growing due to several factors, such as the rise in the ophthalmic issues, growing cases of cataracts in the diabetic population, and rising adoption of advanced premium IOLs. According to the American Academy of Ophthalmology, in 2021, myopia, an eye-focusing disorder, was a significant, prevalent disease that affected an estimated 25% of Americans. Moreover, the rising number of product launches is also driving the market growth during the forecast period. For instance, in January 2023, Bausch + Lomb has completed the acquisition of AcuFocus, a privately owned ophthalmic medical device company. This acquisition gives Bausch + Lomb access to AcuFocus's innovative small aperture non-toric extended depth of focus (EDOF) intraocular lens (IOL) technology, currently available in Australia and New Zealand.
By application, the market is categorized into surgeries, diagnosis, and eye care. Eye care segment is anticipated to grow with significant CAGR during the forecast period. A rising need by the general public to correct and improve their vision due to increasing eye problems, increasing geriatric population, and many other factors are expected to increase the sales of vision care products during the forecast period. Moreover, consumption of poor diet and lack of focus on health are some of the other factors because of which the demand for vision care products and services is expected to increase.
On the basis of end-user, the market is segmented into hospitals, optical centers, and others. In 2022, the hospitals segment held a substantial market share of over 50.0% due to the high volume of cataract and vision repair surgeries conducted within these facilities. As developing regions witness a significant rise in independent ophthalmic clinics, which are not affiliated with hospitals, the competition among eye care service providers is expected to intensify. These clinics, along with an increasing number of eye care practitioners, may attract patients with their competitive pricing, ultimately driving the growth of this segment.
For a better understanding of the market adoption of the limb prosthetics industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America held the dominant share of the market and is expected to do so even in the forecast period. North America is expected to hold a significant market share in the studied market over the forecast period, owing to an increase in vision-related disorders, high adoption of new technologies and products in the healthcare sector, and a surge in demand for better healthcare facilities. Additionally, the increasing prevalence of cataract issues, such as age-related cataracts and congenital cataracts, is anticipated to propel the market's growth over the forecast period. According to statistics published by NVision Centers, in 2022, it was found that about 12 million people aged 40 years and above were suffering from vision impairment in the United States. Similarly, as per the May 2021 update by Fighting Blindness Canada, 1.2 million Canadians were living with vision loss in 2021. As per the same source, 8 million Canadians had an eye condition that could result in blindness. Hence, the market is anticipated to develop due to the rising frequency of eye illnesses and the increased need for intraocular lenses.
Some of the major players operating in the market include Johnson & Johnson; EssilorLuxottica; NIDEK CO., LTD; Ziemer Ophthalmic Systems AG; Bausch + Lomb; ZEISS Group; Tomey Corporation; Alcon; CooperVision, and VisionCare Devices.